A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 24, Issue 7, Pages 1265-1275
Publisher
Springer Nature
Online
2010-05-27
DOI
10.1038/leu.2010.95
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- (2009) F. C. Guibal et al. BLOOD
- PML–RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors
- (2009) S Wojiski et al. LEUKEMIA
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
- (2008) M. A. Sanz et al. BLOOD
- Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells
- (2008) E. Weisberg et al. BLOOD
- Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data
- (2008) D. C. Hassane et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells
- (2008) Peggy Kirstetter et al. CANCER CELL
- The Transcription Factor EGR1 Controls Both the Proliferation and Localization of Hematopoietic Stem Cells
- (2008) Irene M. Min et al. Cell Stem Cell
- Group VI Phospholipases A2: Homeostatic Phospholipases with Significant Potential as Targets for Novel Therapeutics
- (2008) W. Wilkins III et al. CURRENT DRUG TARGETS
- Retinoic acid receptors, hematopoiesis and leukemogenesis
- (2008) Steven J Collins CURRENT OPINION IN HEMATOLOGY
- Calcium-independent phospholipase A2 mediates proliferation of human promonocytic U937 cells
- (2008) María A. Balboa et al. FEBS Journal
- Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.
- (2008) Beata Pajak et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
- (2008) Michael G. Kharas et al. JOURNAL OF CLINICAL INVESTIGATION
- PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
- (2008) S Park et al. LEUKEMIA
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
- (2008) L S Steelman et al. LEUKEMIA
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- Asap: A Framework for Over-Representation Statistics for Transcription Factor Binding Sites
- (2008) Troels T. Marstrand et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started